Publication | Open Access
Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
71
Citations
27
References
2011
Year
The widely used agent ATRA deserves a "second look" in PDAC, but needs to be targeted to patient subsets with biopsy-proven FABP5-negative tumors, or be combined with a chromatin-modifying agent to reexpress endogenous CRABP2.
| Year | Citations | |
|---|---|---|
Page 1
Page 1